Understanding the NSAID related risk of vascular events

Concern is growing over the risk of cardiovascular events such as heart attack or stroke due to thrombosis during the use of COX inhibitors and other non-steroidal anti-inflammatory drugs (NSAIDs). A significant increase in risk has been found in clinical trials.

Saved in:
Bibliographic Details
Published in:BMJ 2006-04, Vol.332 (7546), p.895-898
Main Authors: Vonkeman, Harald E, Brouwers, Jacobus R B J, van de Laar, Mart A F J
Format: Article
Language:English
Subjects:
Anti-Inflammatory Agents, Non-Steroidal - adverse effects
Biological and medical sciences
Cardiovascular disease
Cardiovascular diseases
Cardiovascular Diseases - chemically induced
Cyclooxygenase 1 - physiology
Cyclooxygenase 2 - physiology
Cyclooxygenase 2 Inhibitors - adverse effects
General aspects
Heart attacks
Humans
Inhibitor drugs
Medical sciences
Nonsteroidal anti-inflammatory drugs
Nonsteroidal antiinflammatory drugs
Practice
Risk Factors
Side effects
Stroke
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Concern is growing over the risk of cardiovascular events such as heart attack or stroke due to thrombosis during the use of COX inhibitors and other non-steroidal anti-inflammatory drugs (NSAIDs). A significant increase in risk has been found in clinical trials.
ISSN:0959-8138
0959-8146
0959-535X
1468-5833
1756-1833
DOI:10.1136/bmj.332.7546.895